Navigation Links
Endovascular Forum and GEST Set Out on a Shared Venture to Bring the Highest Level of Embolization-based Scientific and Technical Education, Results, and Relevance for Patient Care
Date:11/11/2009

BOSTON, Nov. 11 /PRNewswire/ -- The Endovascular Forum (EVF), an IC Sciences company, announces today a new partnership with the Global Embolization Symposium and Technologies (GEST), and the launch of a dynamic online case-based interactive forum.

This endeavor is in line with the GEST mission and aim of bringing practitioners the highest level of scientific and technical education about the use of new materials and devices, their results, relevance for patient care, imaging, and to fine tune existing skills and expertise in these areas in the most innovative and dynamic method possible.

"This partnership between GEST, the world's leader in innovative and comprehensive forum for embolization science and education, and the Endovascular Forum, the premier innovative online community for endovascular physicians, is a beautiful match," said Dr. Ziv Haskal, one of the three co-founders of GEST. "We are very excited about linking our community with the far reach and vision of the EVF."

Embolization is one of the few areas in endovascular therapy that draws together all practitioners, regardless of their individual subspecialty practices. Obviously, for the interventional oncologist, embolization is the sine qua non. However, embolization spans peripheral vascular disease, trauma, visceral artery and venous interventions, pediatric and neurointerventional therapies, women's health, aortic disease, vascular malformations, gastrointestinal bleeding, liver disease, non-vascular procedures, cell-based therapies, etc.

In turn embolotherapy has become a central part of daily Interventional Radiology work. Embolization indications have substantially increased over the last decade and continue to do so. Fibroid embolization, trauma, and GI-hemorrhage are only a few areas manifesting this fast increase. Additionally, treatment of vascular malformations is fully dependent on embolization techniques. Oncology treatment with drug
'/>"/>

SOURCE IC Sciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CardioVascularCS.Org, a division of EndoVascular Forum, Inc., Partners with Complex Interventional Cardiovascular Therapy (CICT) to Extend Electronic Medical Care Advancement
2. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
3. Abaxis, Inc. to Present at the Sidoti & Company Second Annual New York Institutional Investor Forum
4. Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum
5. Palatin Technologies to Present at 8th Annual BIO Investor Forum
6. Trubion Announces Upcoming Presentation at 8th Annual BIO Investor Forum
7. Cell Therapeutics, Inc. (CTI) to Present at 8th Annual BIO Investor Forum
8. Novavax to Present at 8th Annual BIO Investor Forum 2009
9. Micromet to Present at The 8th Annual BIO Investor Forum Conference on October 29, 2009
10. VirtualScopics to Present at the 8th Annual Bio Investor Forum
11. Marc J. Fagel of the U.S. Securities and Exchange Commission to Discuss SEC Enforcement at CBIs Biotech/Pharma Finance and Accounting Forum in San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... In conjunction with DURECT Corporation,s (Nasdaq: ... release, you are invited to listen to the conference ... on Thursday, August 7, 2014 at 4:30 pm Eastern ... audio webcast of the presentation will be available by ... "Investor Relations."  If you are unable to participate during ...
(Date:7/30/2014)... , July 30, 2014 The ... Care Pharmacy (AMCP) last evening expressed support for ... the Joint Commission of Pharmacy Practitioners (JCPP).  As ... organizations over a two-year period to develop a ... pharmacists.  "Pharmacists are fast becoming ...
(Date:7/30/2014)... 2014 Research and Markets has announced the ... to 2019" report to their offering. ... grow at a lower CAGR in developed countries; however, it is ... China , India , and ... The growth of the hematology analyzers and reagents market is driven ...
Breaking Medicine Technology:DURECT Corporation Invites You to Join its Second Quarter 2014 Earnings Conference Call 2AMCP Endorses JCPP "Pharmacists' Patient Care Process" 2Hematology Analyzers & Reagents Market - Forecasts to 2019 2
... Georgia has announced the details of their Prostate Cancer ... Georgia in January.  These courses enable the public to become ... All Prostate Cancer Lecture Series seminars are offered free to ... p.m. followed by a lecture at 5:30 p.m. Classes are ...
...  A group of 22 bipartisan House Members yesterday wrote ... asking the agency to stop their prepayment review project ... beneficiaries. The lawmakers, who included Rep. Bill ... job losses, restricted access to mobility equipment for Medicare ...
Cached Medicine Technology:Radiotherapy Clinics of Georgia Present Prostate Cancer Lecture Series 2Bipartisan Group of 22 House Members ask CMS to Stop Prepayment Review Project that would Jeopardize Care for Medicare Beneficiaries 2Bipartisan Group of 22 House Members ask CMS to Stop Prepayment Review Project that would Jeopardize Care for Medicare Beneficiaries 3
(Date:7/30/2014)... AR (PRWEB) July 30, 2014 Throughout ... their patients with free oral cancer screenings. Using a ... will work to detect the disease in its early ... lips, tongue, cheek, mouth, sinuses, throat and other areas ... Cancer Institute’s Surveillance, Epidemiology, and Ends Results (SEER) program, ...
(Date:7/30/2014)... sub-Saharan Africa is being revitalized and expanded through ... broadening curricula, upgrading Internet access and providing cutting-edge ... the first substantial publication by participants of the ... than 225 authors detailed progress being made at ... supplement being published today by the journal ...
(Date:7/30/2014)... Alan Mozes HealthDay Reporter ... who want to help their preschooler shed excess pounds may ... Youngsters whose parents joined them in a supervised behavioral ... enrolled in a traditional child-only program (an average difference of ... benefited, losing almost 15 pounds over two years, according to ...
(Date:7/30/2014)... York (PRWEB) July 30, 2014 The ... brain bleeding has filed a Xarelto lawsuit ( http://www.xareltolawsuitcenter.com/ ... blood thinner, Bernstein Liebhard LLP reports. According to the ... the District of Vermont on July 25th, the decedent ... he suffered an irreversible brain bleed that ultimately led ...
(Date:7/30/2014)... phrase "we caught it early" is possibly the best ... a cancer diagnosis. Combating cancer in its earliest stages, ... of the body, gives patients the best chances of ... and other forms of cancer are touted for saving ... cancer screenings as a precautionary measure, especially for high-risk ...
Breaking Medicine News(10 mins):Health News:Restore Dental Offers Complimentary Oral Cancer Screenings in August 2Health News:Journal supplement details progress in African medical education 2Health News:Journal supplement details progress in African medical education 3Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 2Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 3Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 4Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 3Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 3
... still too early to say that phthalates actually ... (HealthDay News) -- Common chemicals found in plastic toys ... breasts in boys, preliminary research suggests. , The ... adds fuel to the debate over these chemicals, called ...
... up within a week of getting news, researchers say ... can put newly diagnosed prostate cancer patients at increased ... has found. , Researchers analyzed data on 168,584 Swedish ... Of those men, 10,126 (6 percent) experienced a cardiovascular ...
... , LEXINGTON, Ky., Dec. ... confirmed today that VHGI Gold (a wholly owned operating subsidiary ... VHGI advisory board to assist with bringing the Treasure Gulch ... possible. Additionally, the company is informing interested shareholders and related ...
... , , NEW YORK, Dec. ... research report is available in its catalogue: , ... - Market Forecasts to 2015, Competitive Benchmarking, Product ... http://www.reportlinker.com/p0168100/The-Future-of-Autoimmune-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html , Summary , The ...
... Ill. and CHENNAI, India, Dec. 15 Hospira, Inc. ... generic injectable pharmaceuticals, and Orchid Chemicals & Pharmaceuticals Ltd. ... and among the top-five generic beta-lactam antibiotics manufacturers globally, ... generic injectable finished-dosage form pharmaceuticals business for approximately $400 ...
... are often treated with hormones, but when the tumours ... vessels, reveals a thesis from the Sahlgrenska Academy, at ... way for new treatments for hormone-resistant prostate cancer. ... prostate cancer has spread, most patients are given hormone ...
Cached Medicine News:Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 2Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 3Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 2Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 3Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 4Health News:VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled 5Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 23Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 2Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 3Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 4Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 5Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 6Health News:More blood vessels in hormone-resistant prostate tumors 2
... flow while minimizing the pain ... the safety-engineered BD Microtainer Genie ... Lancet offers a full range ... capillary blood collection and protects ...
... Maximize blood flow and minimize pain ... the safety-engineered BD Microtainer Quikheel Lancet. ... surgical blade providing a precise and ... retracts into its casing, helping to ...
DAVINCI® performs all required steps primary tube sampling, reagent dispensing, microplate incubation, washing and optical reading....
The Minilyser offers a combination of three well proven instruments for fully automated processing of microplates. The Minilyser is the optimal fully automated ELISA and EIA equipment for laboratorie...
Medicine Products: